Viewing StudyNCT00095862



Ignite Creation Date: 2024-05-05 @ 11:39 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00095862
Status: TERMINATED
Last Update Posted: 2018-02-05
First Post: 2004-11-09

Brief Title: Vaccine Therapy in Treating Patients With HER2Neu Positive or Negative Stage IV Breast Cancer or Other HER2Neu Positive Cancers
Sponsor: Wiseman Research Initiatives LLC
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Unspecified Adult Solid Tumor Protocol Specific
Breast Cancer
Keywords:
Name View
unspecified adult solid tumor protocol specific View
recurrent breast cancer View
stage IV breast cancer View
male breast cancer View